David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$667M |
| 2 |
NVIDIA
NVDA
|
+$584M |
| 3 |
ConocoPhillips
COP
|
+$432M |
| 4 |
Amazon
AMZN
|
+$418M |
| 5 |
Johnson & Johnson
JNJ
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$836M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
Apple
AAPL
|
+$453M |
| 4 |
CELG
Celgene Corp
CELG
|
+$349M |
| 5 |
Pfizer
PFE
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.27% |
| 2 | Consumer Discretionary | 13.7% |
| 3 | Healthcare | 13.3% |
| 4 | Industrials | 7.34% |
| 5 | Financials | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NTUS
1751
DELISTED
Natus Medical Inc
NTUS
| $3.8M | ﹤0.01% |
148,085
+75,938
| +105% | +$1.94M |
|
1752
Huron Consulting
HURN
$2.5B
| $3.8M | ﹤0.01% |
75,379
-3,894
| -5% | -$191K |
|
1753
Booz Allen Hamilton
BAH
$8.91B
| $3.79M | ﹤0.01% |
57,193
+1,611
| +3% | +$99K |
|
1754
CALL
Bausch Health
BHC
$2.49B
| $3.78M | ﹤0.01% |
150,000
-459,500
| -75% | -$10.9M |
|
1755
PUT
Southwest Airlines
LUV
$20B
| $3.77M | ﹤0.01% |
74,300
-87,600
| -54% | -$4.54M |
|
|
SF
1756
Stifel
SF
$12.2B
| $3.77M | ﹤0.01% |
143,532
+123,856
| +629% | +$3.15M |
|
1757
Lincoln Electric
LECO
$15.8B
| $3.76M | ﹤0.01% |
45,639
+11,497
| +34% | +$956K |
|
1758
CALL
Sea Limited
SE
$73.2B
| $3.75M | ﹤0.01% |
112,900
+52,900
| +88% | +$1.43M |
|
1759
CALL
DexCom
DXCM
$33.4B
| $3.75M | ﹤0.01% |
100,000
| – | – |
|
1760
Sumitomo Mitsui Financial
SMFG
$161B
| $3.75M | ﹤0.01% |
530,616
+383,213
| +260% | +$2.71M |
|
1761
Opko Health
OPK
$1.12B
| $3.74M | ﹤0.01% |
1,531,339
-185,036
| -11% | -$404K |
|
1762
CytomX Therapeutics
CTMX
$721M
| $3.73M | ﹤0.01% |
332,194
-47,560
| -13% | -$499K |
|
1763
Hudbay
HBM
$13.3B
| $3.72M | ﹤0.01% |
687,236
+268,000
| +64% | +$1.59M |
|
|
1764
CALL
ConocoPhillips
COP
$159B
| $3.72M | ﹤0.01% |
61,000
+34,000
| +126% | +$2.12M |
|
1765
Factset
FDS
$10.4B
| $3.72M | ﹤0.01% |
12,979
+9,279
| +251% | +$2.57M |
|
|
MOBL
1766
DELISTED
MobileIron, Inc.
MOBL
| $3.71M | ﹤0.01% |
598,798
-50,987
| -8% | -$289K |
|
1767
Heartland Express
HTLD
$951M
| $3.71M | ﹤0.01% |
205,305
+42,976
| +26% | +$821K |
|
1768
CALL
Salesforce
CRM
$167B
| $3.7M | ﹤0.01% |
24,400
-329,100
| -93% | -$51.6M |
|
|
GAP
1769
PUT
The Gap Inc
GAP
$7.66B
| $3.7M | ﹤0.01% |
+206,000
| New | +$4.62M |
|
1770
Cooper-Standard Automotive
CPS
$472M
| $3.7M | ﹤0.01% |
80,782
+240
| +0.3% | +$11.4K |
|
1771
Protolabs
PRLB
$1.88B
| $3.69M | ﹤0.01% |
31,851
-15,280
| -32% | -$1.64M |
|
1772
Plexus
PLXS
$6.52B
| $3.69M | ﹤0.01% |
63,220
+560
| +0.9% | +$32.3K |
|
1773
Universal Electronics
UEIC
$58.1M
| $3.69M | ﹤0.01% |
89,920
+10,001
| +13% | +$400K |
|
1774
Entravision Communication
EVC
$745M
| $3.69M | ﹤0.01% |
1,181,952
+286,085
| +32% | +$869K |
|
1775
Cabot Corp
CBT
$4.36B
| $3.69M | ﹤0.01% |
77,262
-72,781
| -49% | -$3.27M |
|
Similar funds
David Shaw's Q2 2019 Portfolio in Review
As of Q2 2019, David Shaw held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
David Shaw's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
- David Shaw added most to Alibaba in Q2 2019, an estimated $667M increase.
- David Shaw's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
- David Shaw's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
- David Shaw opened 499 new positions and closed 416 in Q2 2019.
- David Shaw's portfolio value rose 3.6% quarter-over-quarter to $80.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.